Vironova AB - Product Pipeline Review - 2012 - new company profile report published

companiesandmarkets.com

2012-11-15 21:06:52 - Vironova AB - Product Pipeline Review - 2012 - a new company profile report on companiesandmarkets.com

Vironova AB – Product Pipeline Review – 2012 - Global Market Direct´s pharmaceuticals report, "Vironova AB - Product Pipeline Review - 2012" provides data on the Vironova AB´s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced

 

 

from our proprietary databases, Vironova AB´s corporate website, SEC filings, investor presentations and featured press releases, both from Vironova AB and industry-specific third party sources, put together by our team.

Scope

- Vironova AB - Brief Vironova AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Vironova AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Vironova AB with complete description of the product´s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Vironova AB´s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Vironova AB´s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Vironova AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Vironova AB´s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Vironova AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Vironova AB and identify potential opportunities in those areas.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.